Sponsor
CQDM
Program
Canada Europe Joint funding initiative
Description
Eligibility
Must include a strong collaboration between at least one research entity (academic or private) in Canada and at least one private entity in Wallonia.
Funding Availability
Maximum $750,000 EU in Wallonia and $700,000 in Canada.
Indirect Costs
40%
Special Notes
- A research agreement must be signed by all research entities involved in the project within 3 months after the funding confirmation.
- Intellectual property generated under this funding program will be managed according to the policies of the financial partners involved.
- A licence option will be granted to the CQDM industrial sponsors (currently Merck and Pfizer and their subsidiaries) for the use of the results for R&D purposes only. The main conditions of the end user license option will be negotiated before the beginning of the project and will take into account pre- existing IP as well as contribution from each party.
- CDQM industrial sponsors will have no rights to commercialize the IP resulting from the project or the pre-existing IP.
Letter of Intent External Deadline
Candidates should submit their letter of intent before January 8th, 2016 by using the form available on the website [1].
Candidates have until February 8th, 2016 to submit their full application.
Internal Deadline: Please submit a copy of your full application along with a signed OR5 form to the Research Services email address at resserv@uoguelph.ca [2] by 4.30 pm on Monday, January 26, 2016. It is not necessary to submit your letter of intent internally.
Deadlines
If College-level review is required, your College will communicate its earlier internal deadlines.
Type | Date | Notes |
---|---|---|
Internal Deadline | Full Proposal: Please submit a copy of your full application along with a signed OR5 form to the Research Services email address at resserv@uoguelph.ca [2]. It is not necessary to submit your letter of intent internally. | |
External Deadline | For full proposal. |
How to Apply
Please see the LOI and proposal information and forms [1].
Each research proposal must:
- Include strong collaboration between at least one research entity (public or private) in Canada and at least one private entity in Wallonia. In Canada the participation of a private organization is highly encouraged and preferred, but not mandatory, Universities and their hospitals and research centres are eligible.
- Generate clear deliverables with immediate applications in the drug discovery and/or development process of new therapeutics.
- Be highly innovative with a strong and wide potential impact on biopharmaceutical research.